🇺🇸 Glycyrrhetinic Acid in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 1 report (10%)
  2. Bone Marrow Failure — 1 report (10%)
  3. Breast Cancer — 1 report (10%)
  4. C-Reactive Protein Increased — 1 report (10%)
  5. Cell Marker Increased — 1 report (10%)
  6. Cystitis — 1 report (10%)
  7. Death — 1 report (10%)
  8. Immune-Mediated Enterocolitis — 1 report (10%)
  9. Intestinal Obstruction — 1 report (10%)
  10. Peritonitis — 1 report (10%)

Source database →

Glycyrrhetinic Acid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glycyrrhetinic Acid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glycyrrhetinic Acid in United States?

Shandong University is the originator. The local marketing authorisation holder may differ — check the official source linked above.